Wee Joo Chng

6 ta ish

National University of Singapore

1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

   Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos +80

   Sharh maqola20224 iqtibos

   ABIABI:AkademIndex/2026.other.480204

2. CAR T-cell therapy in multiple myeloma: more room for improvement

   Phaik Ju Teoh, Wee Joo Chng

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.296883

3. CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model

   Yu Yang Ng, Zhicheng Du, Xi Zhang +2

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.296892

4. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

   Michèle Cavo, Evangelos Terpos, Cristina Nanni +25

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.466312

5. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

   Hervé Avet‐Loiseau, Faith E. Davies, Mehmet Samur +43

   Maqola20252 iqtibos

   ABIABI:AkademIndex/2026.other.480252

6. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report

   David Murray, Noemí Puig, Sigurður Y. Kristinsson +10

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.890026